1. Home
  2. CBIO vs BRCB Comparison

CBIO vs BRCB Comparison

Compare CBIO & BRCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CBIO

Crescent Biopharma Inc.

HOLD

Current Price

$19.39

Market Cap

557.8M

Sector

N/A

ML Signal

HOLD

BRCB

Black Rock Coffee Bar Inc.

N/A

Current Price

$14.12

Market Cap

225.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CBIO
BRCB
Founded
2003
2008
Country
United States
United States
Employees
44
2800
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
557.8M
225.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CBIO
BRCB
Price
$19.39
$14.12
Analyst Decision
Strong Buy
Buy
Analyst Count
6
7
Target Price
$26.67
$26.83
AVG Volume (30 Days)
221.2K
457.3K
Earning Date
05-23-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$30.74
Revenue Next Year
$279.20
$24.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.72
$11.51
52 Week High
$20.58
$30.40

Technical Indicators

Market Signals
Indicator
CBIO
BRCB
Relative Strength Index (RSI) 71.01 47.54
Support Level $10.89 $13.53
Resistance Level $20.58 $17.60
Average True Range (ATR) 1.91 0.92
MACD 0.20 0.07
Stochastic Oscillator 89.33 64.58

Price Performance

Historical Comparison
CBIO
BRCB

About CBIO Crescent Biopharma Inc.

Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody. Crescent's pipeline product CR-001 has the potential to deliver improved clinical efficacy and safety over pembrolizumab. CR-001 is a new molecular entity designed to replicate the functional properties of ivonescimab, a cooperative bispecific anti-PD-1/anti-VEGF antibody in development by Akeso Biopharma and Summit Therapeutics that delivered improved efficacy in a head-to-head Phase 3 clinical trial versus Keytruda in non-small cell lung cancer. The company focuses on advancing its second and third programs, CR-002 and CR-003, which are antibody drug conjugates (ADCs) against validated oncology targets.

About BRCB Black Rock Coffee Bar Inc.

Black Rock Coffee Bar Inc is an operator of guest-centric, drive-thru coffee bars offering premium caffeinated beverages and an elevated in-store experience crafted by its engaging baristas. The company offers wide variety of coffee from classic espresso-based drinks such as Lattes, Americanos, and Cappuccinos, as well as signature creations like the Caramel Blondie, Mexican Mocha, and Blackout. It offers a variety of savory and sweet items, including breakfast burritos, sausage cheddar sandwiches, banana bread, and glazed donut holes.

Share on Social Networks: